ResearchMoz

Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

GlobalData
Published Date » 2011-05-19
No. Of Pages » 141
 GlobalDatas new report, Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections provides key market data on the United States Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories  Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products,...
Table of Contents

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is This Report About?

3 Drug Delivery Devices In United States
3.1 Drug Delivery Devices, Market Segmentation
3.2 Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017
3.3 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010
3.4 Drug Delivery Devices Market, United States, Category Contribution (%), 2010
3.5 Drug Delivery Devices, United States, Category Volume (Units), 2003-2017
3.6 Drug Delivery Devices, United States, Company Share (2009-2010)

4 Central Venous Catheters In United States
4.1 Central Venous Catheters, Market Segmentation
4.2 Central Venous Catheters Market, United States, Revenue Mix ($m), 2010
4.3 Central Venous Catheters Market, United States, Segment Contribution (%), 2010
4.4 Central Venous Catheters Overall Revenue (2003-2017)
4.5 Central Venous Catheters Overall Volume (2003-2017)
4.6 Central Venous Catheters Average Price (2003-2017)
4.7 Central Venous Catheters Distribution Share (2009-2010)
4.8 Central Venous Catheters, United States, Company Share (2009-2010)

5 Infusion Systems In United States
5.1 Infusion Systems, Market Segmentation
5.2 Infusion Systems Market, United States, Revenue Mix ($m), 2010
5.3 Infusion Systems Market, United States, Segment Contribution (%), 2010
5.4 Infusion Systems Overall Revenue (2003-2017)
5.4.1 Syringe Pumps Revenue (2003-2010)
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010)
5.5 Infusion Systems Overall Volume (2003-2017)
5.5.1 Syringe Pumps Volume (2003-2010)
5.5.2 Ambulatory Infusion Pumps Volume (2003-2010)
5.6 Infusion Systems Average Price (2003-2017)
5.7 Infusion Systems Distribution Share (2009-2010)
5.8 Infusion Systems, United States, Company Share (2009-2010)

6 Metered Dose Inhaler Devices In United States
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017)
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017)
6.3 Metered Dose Inhaler Devices Average Price (2003-2017)
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010)
6.5 Metered Dose Inhaler Devices, United States, Company Share (2009-2010)

7 Needle Free Injections In United States
7.1 Needle Free Injections Overall Revenue (2003-2017)
7.2 Needle Free Injections Overall Volume (2003-2017)
7.3 Needle Free Injections Average Price (2003-2017)
7.4 Needle Free Injections Distribution Share (2009-2010)
7.5 Needle Free Injections, United States, Company Share (2009-2010)

8 Overview of Key Companies in United States Drug Delivery Devices Market
8.1 GlaxoSmithKline plc
8.1.1 Company Overview
8.1.2 Share in the United States Drug Delivery Devices Market
8.2 Hospira, Inc.
8.2.1 Company Overview
8.2.2 Share in the United States Drug Delivery Devices Market
8.3 CareFusion Corporation
8.3.1 Company Overview
8.3.2 Share in the United States Drug Delivery Devices Market
8.4 Boehringer Ingelheim GmbH
8.4.1 Company Overview
8.4.2 Share in the United States Drug Delivery Devices Market
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Share in the United States Drug Delivery Devices Market
8.6 Baxter International Inc.
8.6.1 Company Overview
8.6.2 Share in the United States Drug Delivery Devices Market
8.7 Medtronic, Inc.
8.7.1 Company Overview
8.8 Teleflex Incorporated
8.8.1 Company Overview
8.9 Smiths Medical
8.9.1 Company Overview
8.10 Fresenius Kabi AG
8.10.1 Company Overview
8.11 B. Braun Melsungen AG
8.11.1 Company Overview
8.12 Terumo Corporation
8.12.1 Company Overview
8.13 Consort Medical plc
8.13.1 Company Overview
8.14 3M Health Care
8.14.1 Company Overview
8.15 Edwards Lifesciences Corporation
8.15.1 Company Overview
8.16 Becton, Dickinson and Company
8.16.1 Company Overview
8.17 Cook Medical Incorporated
8.17.1 Company Overview
8.18 INJEX - Equidyne Systems
8.18.1 Company Overview
8.19 Antares Pharma, Inc.
8.19.1 Company Overview
8.20 Bioject Medical Technologies Inc.
8.20.1 Company Overview

9 Drug Delivery Devices Market Pipeline Products

10 Financial Deals Landscape
10.1 Acquisition
10.1.1 CarePoint Partners Acquires Premier Infusion
10.1.2 SurModics Plans The Sale Of SurModics Pharmaceuticals
10.1.3 BTG International To Acquire Biocompatibles
10.1.4 Nordson Completes Acquisition Of Micromedics
10.1.5 Cardinal Health Sells 13.7% Stake In Carefusion
10.1.6 Cellectis Acquires Cyto Pulse Sciences
10.2 Partnerships
10.2.1 Eli Lilly Enters Into Collaboration With Medtronic
10.2.2 West Pharmaceutical Enters Into Agreement With CareFusion
10.2.3 Nile Therapeutics Enters Into An Agreement With Medtronic
10.2.4 Hospira Enters Into An Agreement With Smiths Medical
10.2.5 AorTech International Enters Into Technology License Agreement

11 Recent Developments
11.1 Strategy and Business Planning
11.1.1 Nov 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And Marketing Of Proprietary Transdermal Drug Delivery Products
11.1.2 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units
11.1.3 Aug 31, 2010: Vetter Opens New Sales Office At Illinois Science + Technology Park In Suburban Chicago
11.1.4 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey
11.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring
11.1.6 Jul 14, 2010: GE Healthcare To Shut Down Two Offices In Waukesha
11.1.7 Jul 01, 2010: Shionogi Announces Reorganization Of US Operations
11.1.8 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany
11.2 Legal and Regulatory
11.2.1 Mar 16, 2011: Tekmira Sues Alnylam Pharmaceuticals For Repeated Misuse Of Trade Secrets And Confidential Information
11.2.2 Feb 11, 2011: University Of Florida Research Foundation Initiates Court Case Against Diamyd Medical
11.2.3 Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter
11.2.4 Nov 09, 2010: Greenberg Traurig And Segal McCambridge Singer & MahoneyObtain Three Defense Verdicts For I-Flow In Oregon Infusion Pump Cases
11.2.5 Nov 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions
11.2.6 Sep 03, 2010: BioSphere Agrees To Settle Suit Over Merit Medical merger
11.2.7 Jul 30, 2010: Federal Appeals Court Rules In Favor Of Covidien In Needle Patents Suit
11.2.8 Jul 23, 2010: BioSphere Names In Class Action By Shareholders: SEC Filing
11.2.9 Jun 10, 2010: I-Flow Resolves Patent Infringement, Trade Secret Litigation Against Apex Medical Technologies, Zone Medical
11.3 Government and Public Interest
11.3.1 Mar 16, 2011: Syracuse University Scientists Develop New Drug Delivery System To Improve Cancer Treatment
11.3.2 Feb 17, 2011: Delcath Achieves ISO 13485 Certification
11.3.3 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design
11.3.4 Oct 26, 2010: GERES Study Confirms Passive Safety Devices Are Most Effective In Needlestick Injury Prevention
11.3.5 Aug 31, 2010: Purdue University Researchers Develop New Pump For Microneedle Drug-Delivery Patch
11.3.6 Aug 09, 2010: Talecris Biotherapeutics And Grifols Receive FTC Request For Additional Information Regarding Proposed Merger
11.3.7 Jun 14, 2010: Electronic Cigarettes Are Drug Delivery Devices And Should Be Subject To FDA Regulations: AMA
11.4 Product News
11.4.1 Jul 27, 2010: Dentistry Today Selects Milestone’s STA Single Tooth Anesthesia System For Top 100 Products Award Program
11.4.2 Jul 13, 2010: Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall In US
11.4.3 Jul 08, 2010: Bioject Announces Use Of Its Intradermal Needle-Free Delivery System In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine

12 Appendix
12.1 Definitions of Markets Covered in the Report
12.1.1 Drug Delivery Devices
12.2 Research Methodology
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panels
12.8 GlobalData Consulting
12.9 Currency Conversion
12.10 Contact Us
12.11 Disclaimer

List of Tables


Table 1: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 15
Table 2: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
Table 3: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18
Table 4: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 20
Table 5: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 22
Table 6: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
Table 7: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 25
Table 8: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 27
Table 9: Drug Delivery Devices, United States, Company Share by Revenue ($m), 2009-2010 29
Table 10: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
Table 11: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 34
Table 12: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 36
Table 13: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 38
Table 14: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 40
Table 15: Central Venous Catheters, United States, Average Price ($), Historic, 2003-2010 41
Table 16: Central Venous Catheters, United States, Average Price ($), Forecast, 2010-2017 41
Table 17: Central Venous Catheters, United States, Distribution Share by Revenue ($m), 2009-2010 42
Table 18: Central Venous Catheters, United States, Company Share by Revenue ($m), 2009-2010 44
Table 19: Infusion Systems Market, United States, Segment Contribution (%), 2010 47
Table 20: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 49
Table 21: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 51
Table 22: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53
Table 23: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55
Table 24: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 57
Table 25: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 59
Table 26: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 61
Table 27: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 63
Table 28: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 29: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 30: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 31: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 32: Infusion Systems, United States, Average Price ($), Historic, 2003-2010 70
Table 33: Infusion Systems, United States, Average Price ($), Forecast, 2010-2017 70
Table 34: Infusion Systems, United States, Distribution Share by Revenue ($m), 2009-2010 71
Table 35: Infusion Systems, United States, Company Share by Revenue ($m), 2009-2010 73
Table 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74
Table 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75
Table 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76
Table 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77
Table 40: Metered Dose Inhaler Devices, United States, Average Price ($), Historic, 2003-2010 78
Table 41: Metered Dose Inhaler Devices, United States, Average Price ($), Forecast, 2010-2017 78
Table 42: Metered Dose Inhaler Devices, United States, Distribution Share by Revenue ($m), 2009-2010 79
Table 43: Metered Dose Inhaler Devices, United States, Company Share by Revenue ($m), 2009-2010 81
Table 44: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82
Table 45: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83
Table 46: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84
Table 47: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85
Table 48: Needle Free Injections, United States, Average Price ($), Historic, 2003-2010 86
Table 49: Needle Free Injections, United States, Average Price ($), Forecast, 2010-2017 86
Table 50: Needle Free Injections, United States, Distribution Share by Revenue ($m), 2009-2010 87
Table 51: Needle Free Injections, United States, Company Share by Revenue ($m), 2009-2010 89
Table 52: Drug Delivery Devices Market Pipeline Products 101
Table 53: CarePoint Partners Acquires Premier Infusion 108
Table 54: SurModics Plans The Sale Of SurModics Pharmaceuticals 109
Table 55: BTG International To Acquire Biocompatibles 110
Table 56: Nordson Completes Acquisition Of Micromedics 112
Table 57: Cardinal Health Sells 13.7% Stake In Carefusion 113
Table 58: Cellectis Acquires Cyto Pulse Sciences 114
Table 59: Eli Lilly Enters Into Collaboration With Medtronic 115
Table 60: West Pharmaceutical Enters Into Agreement With CareFusion 116
Table 61: Nile Therapeutics Enters Into An Agreement With Medtronic 117
Table 62: Hospira Enters Into An Agreement With Smiths Medical 118
Table 63: AorTech International Enters Into Technology License Agreement 119
Table 64: USD to Local Currency, United States, Average Actual Rate 2003-2010 141

List of Figures


Figure 1: Drug Delivery Devices, Market Segmentation 13
Figure 2: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14
Figure 3: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16
Figure 4: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
Figure 5: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18
Figure 6: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 19
Figure 7: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 21
Figure 8: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
Figure 9: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 24
Figure 10: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 26
Figure 11: Drug Delivery Devices, United States, Company Share (%), 2010 28
Figure 12: Central Venous Catheters, Market Segmentation 30
Figure 13: Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31
Figure 14: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
Figure 15: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 33
Figure 16: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 35
Figure 17: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 37
Figure 18: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 39
Figure 19: Central Venous Catheters, United States, Company Share (%), 2010 43
Figure 20: Infusion Systems, Market Segmentation 45
Figure 21: Infusion Systems Market, United States, Revenue Mix ($m), 2010 46
Figure 22: Infusion Systems Market, United States, Segment Contribution (%), 2010 47
Figure 23: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 48
Figure 24: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 50
Figure 25: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Figure 26: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Figure 27: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Figure 28: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Figure 29: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 60
Figure 30: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 62
Figure 31: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Figure 32: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, United States, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75
Figure 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76
Figure 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77
Figure 40: Metered Dose Inhaler Devices, United States, Company Share (%), 2010 80
Figure 41: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82
Figure 42: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83
Figure 43: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84
Figure 44: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85
Figure 45: Needle Free Injections, United States, Company Share (%), 2010 88
Figure 46: GlaxoSmithKline plc, Company Share (%),United States Drug Delivery Devices Market, 2010 90
Figure 47: Hospira, Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 91
Figure 48: CareFusion Corporation, Company Share (%),United States Drug Delivery Devices Market, 2010 92
Figure 49: Boehringer Ingelheim GmbH, Company Share (%),United States Drug Delivery Devices Market, 2010 93
Figure 50: AstraZeneca PLC, Company Share (%),United States Drug Delivery Devices Market, 2010 94
Figure 51: Baxter International Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 95

Upcoming Reports:

Poland: refrigerators and freezers market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the refrigerators and freezers market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the refrigerators and freezers market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents...
Circadian Rhythm Sleep Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Sleep disorder is a deviation in the normal sleeping pattern. It can also be defined as difficulty related to sleeping that includes falling asleep at inappropriate time, excessive sleep and abnormal behavior associated with the sleep. Sleep disorders are classified into four categories namely, dyssomnias, parasomnias, proposed sleep disorder and medical disorder. Dyssomnia is the disturbance in quality, time and amount of sleep. It is further classified as intrinsic sleep disorder, circadian rhythm sleep disorder and extrinsic sleep disorder. Circadian Rhythm Sleep Disorders...
Low Emission Vehicle Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
A hybrid vehicle is the combination of traditional engines and electric vehicles. They use features of both traditional and electric systems to reduce the emission levels of gases. Traditional engines, which run on fuels such as diesel and gasoline, are scarce and they emit a variety of gases such as carbon dioxide, carbon monoxide, etc. Currently, the market is dominated by traditional engine based vehicles with several manufacturers and suppliers, which has resulted in faster consumption of fossil fuels and increased emission levels. Regulatory bodies and auto manufacturers are...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...